NADPH cytochrome P-450 oxidoreductase and susceptibility to ketoconazole

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 7, 1998, Pages 1756-1761

  Venkateswarlu, K ^b   Kelly, Diane E ^a   Manning, Nigel J ^c   Kelly, Steven L ^a,b  

^a ABERYSTWYTH UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 REDUCTASE; KETOCONAZOLE;

ARTICLE; CONFORMATIONAL TRANSITION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SENSITIVITY; ENZYME ASSAY; ENZYME CONFORMATION; GENETIC TRANSFORMATION; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; STEROID METABOLISM; STRAIN DIFFERENCE;

EID: 0031863589     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.7.1756     Document Type: Article

References (30)

1. Aoyama, Y., Y. Yoshida, Y. Sonoda, and Y. Sato. 1989. Metabolism of 32-hydroxy-24,25-dihydrolanosterol by purified cytochrome P45014DM from yeast. J. Biol. Chem. 264:18502-18505.
2. Baily, G. G., F. M. Perry, D. W. Denning, and B. K. Mandal. 1994. Fluconazole-resistant candidosis in an HIV cohort. AIDS 8:787-792.
3. 22-desaturation in ergosterol biosynthesis of yeast. Agric. Biol. Chem. 51:1349-1354.
4. Imai, Y. 1981. The roles of cytochrome-b5 in reconstituted mono-oxygenase systems containing various forms of hepatic microsomal cytochrome P-450. J. Biochem. 89:351-362.
5. Jefcoate, J. R. 1979. Measurement of substrate and inhibitor binding to microsomal cytochrome P-450 by optical-difference spectroscopy. Methods Enzymol. 52:258-279.
6. Jones, J. S., and L. Prakash. 1990. Yeast Saccharomyces cerevisiae selectable markers in pUC18 polylinkers. Yeast 6:363-366.
7. Kalb, V. F., C. W. Woods, T. G. Turi, C. R. Dey, T. R. Sutter, and J. C. Loper. 1987. Primary structure of the P450 lanosterol demethylase gene from Saccharomyces cerevisiae. DNA 6:529-537.
8. Kalb, V. F., J. C. Loper, C. R. Dey, C. W. Woods, and T. R. Sutter. 1986. Isolation of a cytochrome P-450 structural gene from Saccharomyces cerevisiae. Gene 45:237-245.
9. Kelly, S. L., D. C. Lamb, A. J. Corran, B. C. Baldwin, and D. E. Kelly. 1995. Mode of action and resistance of azoic antifungals associated with the formation of 14α-methylergosta-8,24(28)-dien-3β,6α-diol. Biochem. Biophys. Res. Commun. 207:910-905.
10. 22-desaturase. FEBS Lett. 377:217-220.
11. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 277:333-346.
12. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239: 2370-2378.
13. Quail, M. A., A. Arnoldi, D. J. Moore, M. W. Goosey, and S. L. Kelly. 1993. Ketoconazole mediated growth inhibition in Botrytis cinera and Saccharomyces cerevisiae. Phytochemistry 32:273-280.
14. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
15. Sevrioukova, I. F., and J. A. Peterson. 1995. NADPH-P-450 reductase: structural and functional comparisons of the eukaryotic and prokaryotic isoforms. Biochimie 77:562-572.
16. Shyadehi, A. Z., D. C. Lamb, S. L. Kelly, D. E. Kelly, W.-H. Schunck, N. Wright, D. Corina, and M. Akhtar. 1996. The mechanism of the acyl-carbon bond-cleavage reaction catalyzed by recombinant sterol 14α-demethylase of Candida albicans (other names are lanosterol 14α-demethylase, P-450 [14DM], and CYP51). J. Biol. Chem. 271:12445-12450.
17. Skaggs, B. A., J. F. Alexander, C. A. Pierson, K. S. Schweitzer, K. T. Chun, C. Koegel, R. Barbuch, and M. Bard. 1996. Cloning and characterization of the Saccharomyces cerevisiae C-22 sterol desaturase gene, encoding a 2nd cytochrome P-450 involved in ergosterol biosynthesis. Gene 169:105-109.
18. Sutter, T. R., and J. C. Loper. 1989. Disruption of the Saccharomyces cerevisiae gene for NADPH-cytochrome P-450 reductase causes increased sensitivity to ketoconazole. Biochem. Biophys. Res. Commun. 160:1257-1266.
19. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
20. 5-encoding gene which suppresses ketoconazole hypersensitivity in a NADPH-P-450 reductase-deficient strain. Gene 149:123-127.
21. Vanden Bossche, H., P. Marichal, F. C. Odds, L. Le Jeune, and M. C. Coene. 1992. Characterization of an azole-resistant Candida glabrata isolate. Antimicrob. Agents Chemother. 36:2602-2610.
22. van den Brink, J. M. H., J. G. M. H. van Nistelrooy, M. A. de Waard, A. M. J. J. C. van den Hondel, and R. F. M. van Gorcom. 1996. Increased resistance to 14α-demethylase inhibitors (DMIs) in Aspergillus niger by coexpression of the Penicillium italicum eburicol 14α-demethylase (ryp51) and the A. niger cytochrome P450 reductase (cprA) genes. J. Biotechnol. 49:13-18.
23. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1996. Comparison of D0870, a new triazole antifungal agent, to fluconazole for inhibition of Candida albicans cytochrome P-450 by using in vitro assays. Antimicrob. Agents Chemother. 40:1382-1386.
24. Venkateswarlu, K., D. W. Denning, N. J. Manning, and S. L. Kelly. 1995. Resistance to fluconazole in Candida albicans from AIDS patients correlated with reduced intracellular accumulation of drug. FEMS Microhiol. Lett. 131: 337-341.
25. Vermillion, J. L., D. P. Ballou, V. Massey, and M. J. Coon. 1981. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem. 256:266-277.
26. Vermillion, J. L., and M. J. Coon. 1978. Purified liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem. 253:2694-2704.
27. Weete, J. D. 1989. Structure and functions of sterols in fungi. Adv. Lipid Res. 23:115-167.
28. Yabusaki, Y., H. Murakami, and H. Ohkawa. 1988. Primary structure of Saccharomyces cerevisiae NADPH-cytochrome P450 reductase deduced from nucleotide sequence of its cloned gene. J. Biochem. 103:1004-1010.
29. Yoshida, Y. 1988. Cytochrome P450 of fungi: primary target for azole antifungal agents. Curr. Top. Med. Mycol. 2:388-418.
30. 14DM purified from Saccharomyces cerevisiae microsomes. Biochem. Pharmacol. 36:229-235.